MGMT METHYLATION IS A PROGNOSTIC BIOMARKER IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

Spremljeno u:
Bibliografski detalji
Glavni autori: Gerstner, E R., Yip, S, Wang, D L., Louis, D N., Iafrate, A J., Batchelor, T T.
Format: Artigo
Jezik:Inglês
Izdano: American Academy of Neurology 2009
Teme:
Clinical/Scientific Notes
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2779003/
https://ncbi.nlm.nih.gov/pubmed/19884580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3181bf9907
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items